ORMP
ORMP

Oramed Pharmaceuticals Inc

NASDAQ · Pharmaceuticals
$3.41
+0.17 (+5.25%)
Analyst Consensus
Strong Sell
6 analysts
Buy 0 0%
Hold 3 50%
Sell 3 50%
Price Target
Analyst Price Target +180.1% upside
Low Target $5.95
Average Target $9.55
High Target $10.69
Current Price $3.41
Current
$3.41
Target
$9.55
$5.95 $9.55 avg $10.69